title: Uptake of mannose-terminal glucocerebrosidase in cultured human cholinergic and dopaminergic neuron cell lines.
abstract: Enzyme replacement therapy has been shown to be particularly effective for patients with type 1 (non-neuronopathic) Gaucher disease. However, intravenously administered glucocerebrosidase does not reverse or halt the progression of brain damage in patients with type 2 (acute neuronopathic) Gaucher disease. A previous investigation revealed that intracerebral infusion of mannose-terminal glucocerebrosidase was safe in experimental animals. The enzyme had a comparatively long half-life in the brain. It was transported by convection from the site of infusion along white matter fiber tracts to the cerebral cortex where it was endocytosed by neurons. In anticipation of intracerebral administration of mannose-terminal glucocerebrosidase to patients with type 2 Gaucher disease, it was important to learn the mechanism involved in its cellular uptake. We therefore compared the endocytosis of this enzyme by J774 macrophage cells with that in two human neuronal cell lines and a human astrocyte cell line. Mannose-terminal glucocerebrosidase was taken up by cholinergic LA-N-2 cells, but to a much lower extent than by macrophages. Considerably less of the enzyme was endocytosed by dopaminergic SH-SY5Y cells. It was not taken up by NHA astrocytes. The findings provide encouragement for an exploration of intracerebral administration of glucocerebrosidase in patients with type 2 Gaucher disease.
authors.affiliation: Developmental and Metabolic Neurology Branch, NINDS, NIH, Bethesda, Maryland 20892, USA. Ulrike@codon.nih.gov
authors.forename: U
authors.initials: U
authors.lastname: Schueler
authors.forename: C
authors.initials: C
authors.lastname: Kaneski
authors.forename: G
authors.initials: G
authors.lastname: Murray
authors.forename: K
authors.initials: K
authors.lastname: Sandhoff
authors.forename: R O
authors.initials: RO
authors.lastname: Brady
mesh_terms: D000109:Acetylcholine / Q000378:metabolism*; D001692:Biological Transport; D002454:Cell Differentiation; D002460:Cell Line; D002478:Cells, Cultured; D003470:Culture Media; D004299:Dopamine beta-Hydroxylase / Q000378:metabolism*; D005776:Gaucher Disease / Q000201:enzymology; D005962:Glucosylceramidase / Q000378:metabolism*; D006801:Humans; D007700:Kinetics; D008358:Mannose; D009474:Neurons / Q000166:cytology / Q000201:enzymology*
chemical_list: D003470:Culture Media; D004299:Dopamine beta-Hydroxylase; D005962:Glucosylceramidase; D000109:Acetylcholine; D008358:Mannose